NCT04014972

Brief Summary

Chinese Cardiovascular Association is an association dedicated to establishing Chest Pain Centers in hospitals that have basic qualifications and meet pre-designed quality control targets.The vision of Chinese Cardiovascular Association is the cardiovascular health of every Chinese, and the mission is to realize the early arrival of the inflection point of cardiovascular events in China.The institute of China Heart House is responsible for the daily management and implementation of Chinese Cardiovascular Association and the implementation and management of the Chest Pain Center construction project.In order to improve standard treatment and chest pain system management to achieve better outcomes for patients, China Heart House established the chest pain center database.The database includes patients in 4129 registered hospitals in 31 provinces in China who have been admitted with chest pain.The database can reflect the clinical characteristics, treatment and outcome of patients with chest pain in China. This non-interventional, retrospective study analyzed the chest pain center database to understand the demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with chest pain, and to analyze the effects of different treatment patterns, including chest pain centers and related collaborative treatment networks.The results of the study will assess the gap between the real-world situation and the recommendations of the guidelines and reflect the effect of chest pain centers and related collaborative treatment networks on the treatment process and service quality.The research results can be directly translated into the basis of medical treatment system intervention, and also provide decision-making reference for improving the certification standards and quality control of chest pain centers.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 10, 2019

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

July 10, 2019

Status Verified

July 1, 2019

Enrollment Period

1 month

First QC Date

July 3, 2019

Last Update Submit

July 9, 2019

Conditions

Outcome Measures

Primary Outcomes (8)

  • mean and standard deviation of STEMI (ST-segment elevated Myocardial Infarction)patients

    mean and standard deviation of STEMI patients

    baseline

  • Proportion of STEMI (ST-segment elevated Myocardial Infarction)patients

    Proportion of female STEMI patients

    baseline

  • emergency information of STEMI patients

    Path to hospital First medical contact time Does the patient circumvent emergency Telecardiogram transmission STEMI Reperfusion Therapy Initiation time of interventional surgery Catheter chamber activation time Time of arrival of patient in catheter room Guide wire passage time D2B time

    baseline

  • admission status of STEMI patients

    admission status of STEMI patients

    baseline

  • hospitalization evaluation of STEMI patients

    value of serum troponin and serum creatinin of STEMI patients

    baseline

  • In-hospital mortality of STEMI patients

    In-hospital mortality of STEMI patients

    baseline

  • Hospitalization days of STEMI patients

    Hospitalization days of STEMI patients

    baseline

  • Total cost of STEMI patients

    Total cost of STEMI patients

    baseline

Study Arms (1)

Patients with Myocardial Infarction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population was inpatients (18 years and older) admitted to the Chest Pain Central database with symptoms of chest pain.The database registration of this study was conducted in 4129 registered hospitals in 31 provinces in China.All hospitals participating in the Chest Pain Center program are encouraged to manage patients in accordance with local standard practices (as recommended by current Chinese guidelines). This study will include data on all patients in the chest pain central database.

You may qualify if:

  • age 18 and above
  • patients admitted with chest pain
  • diagnosis is made by the treating physician based on local practice and clinical judgment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Central Study Contacts

Huo Yong, master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 10, 2019

Study Start

July 1, 2019

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

July 10, 2019

Record last verified: 2019-07